share_log

Piper Sandler Maintains Overweight on Health Catalyst, Raises Price Target to $12

Benzinga ·  Dec 22, 2023 10:39

Piper Sandler analyst Jessica Tassan maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and raises the price target from $11 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment